✦ LIBER ✦

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ Scribed by Sylvester, Richard; Oosterlinck, Willem; Brausi, Maurizio; Kirkels, Wim J; Da Silva, Fernando Calais; Gorlia, Thierry; Kirkali, Ziya

Book ID: 123058108
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 146 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61718-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; W. Oosterlinck; M.A. Brausi; W.J. Kirkels; F. Calais Da Silva; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

LONG-TERM EFFICACY RESULTS OF EORTC GU G

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTE- GUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 BLADDER CARCINOMA

✍ Sylvester, Richard; Brausi, Maurizio; Hoeltl, Wolfgang; Powell, Philip; Whelan, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 138 KB

659 EFFECT OF AGE ON TREATMENT OUTCOME A

659 EFFECT OF AGE ON TREATMENT OUTCOME AND TOLERANCE IN PATIENTS WITH STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE BACILLUS CALMETTEGUERIN: RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; M.A. Brausi; W.J. Kirkels; J. Oddens; W. Hoeltl; G. Van Andel; T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 506 KB

The Effect of Age on the Efficacy of Mai

The Effect of Age on the Efficacy of Maintenance Bacillus Calmette-Guérin Relative to Maintenance Epirubicin in Patients with Stage Ta T1 Urothelial Bladder Cancer: Results from EORTC Genito-Urinary Group Study 30911

✍ Oddens, Jorg R.; Sylvester, Richard J.; Brausi, Maurizio A.; Kirkels, Wim J.; va 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 593 KB

LONG-TERM EFFICACY RESULTS OF EORTC GU G

LONG-TERM EFFICACY RESULTS OF EORTC GU GROUP STUDY 30911 COMPARING EPIRUBICIN, BACILLUS CALMETTEGUERIN (BCG), AND BCG PLUS ISONIAZID IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER

✍ R.J. Sylvester; M.A. Brausi; W. Hoeltl; P.H. Powell; P. Whelan; T. Gorlia; T.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB